chr5-1280013-T-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_198253.3(TERT):​c.1950+145A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.429 in 1,079,128 control chromosomes in the GnomAD database, including 102,532 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18906 hom., cov: 34)
Exomes 𝑓: 0.42 ( 83626 hom. )

Consequence

TERT
NM_198253.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.819

Publications

22 publications found
Variant links:
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dyskeratosis congenita, autosomal dominant 2
    Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma, cutaneous malignant, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-1280013-T-C is Benign according to our data. Variant chr5-1280013-T-C is described in ClinVar as Benign. ClinVar VariationId is 1267625.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERTNM_198253.3 linkc.1950+145A>G intron_variant Intron 4 of 15 ENST00000310581.10 NP_937983.2
TERTNM_001193376.3 linkc.1950+145A>G intron_variant Intron 4 of 14 NP_001180305.1
TERTNR_149162.3 linkn.2029+145A>G intron_variant Intron 4 of 12
TERTNR_149163.3 linkn.2029+145A>G intron_variant Intron 4 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TERTENST00000310581.10 linkc.1950+145A>G intron_variant Intron 4 of 15 1 NM_198253.3 ENSP00000309572.5

Frequencies

GnomAD3 genomes
AF:
0.487
AC:
74016
AN:
152026
Hom.:
18867
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.469
Gnomad EAS
AF:
0.399
Gnomad SAS
AF:
0.398
Gnomad FIN
AF:
0.459
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.422
Gnomad OTH
AF:
0.489
GnomAD4 exome
AF:
0.419
AC:
388845
AN:
926984
Hom.:
83626
AF XY:
0.418
AC XY:
199137
AN XY:
476470
show subpopulations
African (AFR)
AF:
0.668
AC:
15453
AN:
23126
American (AMR)
AF:
0.308
AC:
12385
AN:
40196
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
9611
AN:
21058
East Asian (EAS)
AF:
0.374
AC:
13725
AN:
36670
South Asian (SAS)
AF:
0.399
AC:
27822
AN:
69798
European-Finnish (FIN)
AF:
0.458
AC:
20903
AN:
45682
Middle Eastern (MID)
AF:
0.455
AC:
1488
AN:
3272
European-Non Finnish (NFE)
AF:
0.417
AC:
269055
AN:
644830
Other (OTH)
AF:
0.435
AC:
18403
AN:
42352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11515
23030
34545
46060
57575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6400
12800
19200
25600
32000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.487
AC:
74109
AN:
152144
Hom.:
18906
Cov.:
34
AF XY:
0.482
AC XY:
35877
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.666
AC:
27638
AN:
41486
American (AMR)
AF:
0.373
AC:
5706
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.469
AC:
1625
AN:
3468
East Asian (EAS)
AF:
0.398
AC:
2057
AN:
5164
South Asian (SAS)
AF:
0.397
AC:
1917
AN:
4834
European-Finnish (FIN)
AF:
0.459
AC:
4867
AN:
10598
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.422
AC:
28704
AN:
67990
Other (OTH)
AF:
0.496
AC:
1048
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1905
3810
5714
7619
9524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.436
Hom.:
6227
Bravo
AF:
0.488
Asia WGS
AF:
0.455
AC:
1585
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
7.7
DANN
Benign
0.35
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.26
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.26
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7734992; hg19: chr5-1280128; COSMIC: COSV57212982; API